# An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine

> **NCT01807455** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 12 (actual)

## Conditions studied

- Acne Scars

## Interventions

- **DEVICE:** Restylane Vital Lidocaine

## Key facts

- **NCT ID:** NCT01807455
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01807455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01807455, "An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01807455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*